Departamento de Química Orgánica, Facultad de Farmacia, Universidad de Santiago de Compostela, E-15782, Santiago de Compostela, Spain.
Bioorg Med Chem Lett. 2009 Nov 1;19(21):6059-62. doi: 10.1016/j.bmcl.2009.09.041. Epub 2009 Sep 17.
A series of 8 new tetrahydroquinazolinone derivatives was synthesized and evaluated for binding affinity to D2 and 5-HT2A human receptors; in addition, some properties related to blood-brain barrier penetration were calculated. From the results of these assays, three compounds were selected for further binding tests on D1, D3, and 5-HT2C human receptors, which are thought to be involved in schizophrenia. From these data, compound 19b emerged as the most promising candidate based on its good binding affinities for D1, D2, and D3 receptors, high affinity for 5-HT2A, low affinity for 5-HT2C receptors, and a Meltzer's ratio characteristic of an atypical antipsychotic profile.
合成了一系列 8 种新的四氢喹唑啉酮衍生物,并评估了它们与 D2 和 5-HT2A 人受体的结合亲和力;此外,还计算了一些与血脑屏障穿透性相关的性质。根据这些测定结果,选择了三种化合物进一步在 D1、D3 和 5-HT2C 人受体上进行结合测试,这些受体被认为与精神分裂症有关。根据这些数据,化合物 19b 脱颖而出,成为最有前途的候选药物,因为它对 D1、D2 和 D3 受体具有良好的结合亲和力,对 5-HT2A 具有高亲和力,对 5-HT2C 受体的亲和力较低,并且具有梅尔策比(Meltzer's ratio)特征,表明其具有非典型抗精神病药物的特征。